Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition

• Ngā kaituhi matua: Jing Ma (Author), Lu Ding (Author), Xiaoyu Zang (Author), Ruonan Wei (Author), Yingying Yang (Author), Wei Zhang (Author), Hang Su (Author), Xueyan Li (Author), Min Li (Author), Jun Sun (Author), Zepeng Zhang (Author), Zeyu Wang (Author), Daqing Zhao (Author), Xiangyan Li (Author), Linhua Zhao (Author), Xiaolin Tong (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

BackgroundPulmonary fibrosis (PF) emerges as a significant pulmonary sequelae in the convalescent phase of coronavirus disease 2019 (COVID-19), with current strategies neither specifically preventive nor therapeutic. Licoricesaponin G2 (LG2) displays a spectrum of natural activities, including antib...